Journey Medical (DERM) Accumulated Expenses (2020 - 2026)

Journey Medical (DERM) has reported Accumulated Expenses for 7 consecutive years, with $31.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses rose 41.13% year-over-year to $31.8 million; the trailing twelve-month figure through Jun 2026 stood at $31.8 million (up 41.13% YoY), and the FY2025 full-year result was $27.6 million, up 58.2% from the prior year.
• Accumulated Expenses grew to $31.8 million in Q2 2026 per DERM's latest filing, from $26.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $31.8 million in Q2 2026 and bottomed at $16.0 million in Q2 2024.
• Historically, Accumulated Expenses has averaged $21.2 million across 5 years, with a median of $20.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses tumbled 32.88% in 2023, then jumped 58.2% in 2025.
• Over 5 years, Accumulated Expenses stood at $19.4 million in 2022, then rose by 4.96% to $20.3 million in 2023, then declined by 14.37% to $17.4 million in 2024, then surged by 58.2% to $27.6 million in 2025, then gained by 15.47% to $31.8 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $31.8 million, $26.1 million, and $27.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.